glp-1 agonist eli lilly Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes Administration Anounces Landmark GLP-1 Pricing

10.1038/s41591-019-0423-5 299 WeiZ.SongJ.WangG.CuiX.ZhengJ.TangY.et al

While earlier GHRPs activate multiple endocrine pathways causing spikes in cortisol, ACTH, prolactin, and appetite alongside GH ipamorelin produces a much cleaner GH-specific response

are inventors on patents related to this work (PCT/KR2021/003127 & PCT/KR2021/003128)

Fluorescence intensity for surface antigens and intracellular cytokines was detected by flow cytometry, on viable (SSC Vs FSC) gated cells, using a BD FACS Canto II analyser

1 (Table 1)

Saturated fat increased liver fat 70% more than fructose in a randomized controlled trial